Shukla Abhinav A.
Known title: Chief Technical OfficerCIK: 0001923377
Associated companies
Transaction History
| STTK | ▲ Buy | Option Exercise | 12,153 | $43K | 7/6/2026 | View on chart |
| STTK | ▲ Buy | Option Exercise | 410 | $1K | 7/2/2026 | View on chart |
| STTK | ▼ Sell | Open Market | 410 | $3K | 7/2/2026 | View on chart |
| STTK | ▲ Buy | Option Exercise | 100 | $357 | 7/1/2026 | View on chart |
| STTK | ▼ Sell | Open Market | 100 | $707 | 7/1/2026 | View on chart |
| STTK | ▲ Buy | Option Exercise | 23,365 | $83K | 6/30/2026 | View on chart |
| STTK | ▼ Sell | Open Market | 23,365 | $165K | 6/30/2026 | View on chart |
| STTK | ▲ Buy | Grant | 5,122 | $6K | 5/21/2026 | View on chart |
| STTK | ▲ Buy | Option Exercise | 2,032 | $7K | 5/12/2026 | View on chart |
| STTK | ▼ Sell | Open Market | 2,032 | $14K | 5/12/2026 | View on chart |
| STTK | ▲ Buy | Grant | 5,122 | $4K | 8/25/2025 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 2,261 | $3K | 1/25/2025 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 4,830 | $6K | 1/10/2025 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 2,290 | $23K | 1/30/2024 | View on chart |
| STTK | ▲ Buy | Grant | 33,425 | $0 | 1/10/2024 | View on chart |
| STTK | ▲ Buy | Grant | 26,100 | $0 | 1/25/2023 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 1,933 | $6K | 1/10/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
UBS initiates coverage on Shattuck Labs with $17 price target
UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.
UBS initiates coverage on Shattuck Labs with $17 price target. UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.